Deleted Tweets From Scott Gottlieb, R-D.C.

Recalled eggs sold under multiple brand including Coburn Farms, Country Daybreak, Food Lion, Glenview, Great Value, Nelms, Sunshine Farms https://t.co/avbXxL1B05 Consumers with these eggs shouldn’t eat them. Throw them away or return them to place of purc

#FDA is working on new policies to promote drug competition and, in particular, to make sure generic firms can get access to the branded drugs doses they need in order to run the studies required for #FDA approval of a new generic medicine https://t.co/wF

RT @bioitworld: Scott Gottlieb Announces 3 New FDA Guidances Focused On NGS, In Vitro Diagnostic Development https://t.co/HiD0GJjPxO

RT @tmprowell: We must provide greater access to investigational drugs for those living w/ cancer. Ideally this is in context of #clinical… QT @DrCFord: #AACR2018 & we’re off! @tmprowell giving a great overview of modernising clinical trial design, particularly broadening patient eligibility.)

#FDA announced new policies aimed at advancing the development of beneficial, next generation sequencing tools and drug/device systems for the diagnosis of cancer https://t.co/GPjY2NT1Jb https://t.co/DtfQ6Tm2sR

RT @FDAOncology: A growing number of regulatory submissions are incorporating #RWE. Hear more from #FDAOncology's Sean Khozin… https://t.co/y1Zk2QVG4l

RT @endpts: Next-generation sequencing: FDA offers guidance to streamline path to market https://t.co/GW1A7W0lYF by @ZacharyBrennan via @RAPSorg

RT @califf001: Glad to see this getting done. Overall caffeine is good, but when concentrated to lethal amounts requiring careful titratio… QT @NBCNewsHealth: Bulk caffeine kills and FDA says it's pulling it off the market https://t.co/Hyls7jsgSh)

RT @AJMC_Journal: At #COA2018, @SGottliebFDA provided the audience with an overview of current and future plans of the regulatory age… https://t.co/kspI7z1Aq5

RT @SeanKhozin: #FDA is taking proactive steps to harness the power of #HealthIT & #digitalhealth to advance its public health mission as t… QT @SGottliebFDA: A growing number of regulatory submissions are incorporating real world evidence to support observations on safety… https://t.co/TxVeaNMOnp)

RT @FDA_Drug_Info: #FDA launches Model-Informed Drug Development (MIDD) Pilot Program: https://t.co/DMAl4PSFv4.

RT @FDA_ORA: How many arrests did #OCI make last year? How many warning letters were issued? Learn all about #FDAORA 2017 achiev… https://t.co/Y753ErJtXj

RT @foodsafetygov: Do you have recalled eggs at home? Throw them out or return them. Wash and sanitize refrigerator drawers and shelve… https://t.co/qwO7vd61Ck

I want to thank @FrankPallone and @RutgersU for hosting me in my home state NJ today to tour innovation being led by Rutgers in continuous manufacturing. These manufacturing methods hold out much public health promise and #FDA appreciates @FrankPallone le

Today, patients with opioid use disorder will share experiences with #FDA in a public mtg; part of our work to encourage patient-focused development of new treatments for OUDs. We want to hear from patients about current treatments and what barriers stand

RT @FDAMedia: Statement from @SGottliebFDA on new efforts to enhance and modernize the FDA’s approach to medical device safety an… https://t.co/AjPV65a73n

RT @RAPSorg: Model-Informed Drug Development: Details on @US_FDA Pilot Project | #Regulatory Focus https://t.co/gzZWDKpfoL #FDA #pharma #PDUFA

Like our efforts around tobacco, #FDA’s comprehensive nutrition strategy is one of our greatest opportunities to have a profound and generational impact on human health https://t.co/AnOhC21qtI

RT @BioCentury: FDA launches model-informed drug development pilot https://t.co/CV1CxmDNdm

For #PFDD meeting on chronic pain, #FDA is interested in hearing from patients who experience chronic pain managed w/ analgesic medications (opioids, acetaminophen, NSAIDs, antidepressants, other medications) or non-pharmacologic interventions/therapies:

Recalled eggs sold under multiple brand including Coburn Farms, Country Daybreak, Food Lion, Glenview, Great Value, Nelms, Sunshine Farms https://t.co/avbXxL1B05 Consumers with these eggs shouldn’t eat them. Throw them away or return them to place of purc

#FDA is working on new policies to promote drug competition and, in particular, to make sure generic firms can get access to the branded drugs doses they need in order to run the studies required for #FDA approval of a new generic medicine https://t.co/wF

RT @bioitworld: Scott Gottlieb Announces 3 New FDA Guidances Focused On NGS, In Vitro Diagnostic Development https://t.co/HiD0GJjPxO

RT @tmprowell: We must provide greater access to investigational drugs for those living w/ cancer. Ideally this is in context of #clinical… QT @DrCFord: #AACR2018 & we’re off! @tmprowell giving a great overview of modernising clinical trial design, particularly broadening patient eligibility.)

#FDA announced new policies aimed at advancing the development of beneficial, next generation sequencing tools and drug/device systems for the diagnosis of cancer https://t.co/GPjY2NT1Jb https://t.co/DtfQ6Tm2sR

RT @FDAOncology: A growing number of regulatory submissions are incorporating #RWE. Hear more from #FDAOncology's Sean Khozin… https://t.co/y1Zk2QVG4l

RT @endpts: Next-generation sequencing: FDA offers guidance to streamline path to market https://t.co/GW1A7W0lYF by @ZacharyBrennan via @RAPSorg

RT @califf001: Glad to see this getting done. Overall caffeine is good, but when concentrated to lethal amounts requiring careful titratio… QT @NBCNewsHealth: Bulk caffeine kills and FDA says it's pulling it off the market https://t.co/Hyls7jsgSh)

RT @AJMC_Journal: At #COA2018, @SGottliebFDA provided the audience with an overview of current and future plans of the regulatory age… https://t.co/kspI7z1Aq5

RT @SeanKhozin: #FDA is taking proactive steps to harness the power of #HealthIT & #digitalhealth to advance its public health mission as t… QT @SGottliebFDA: A growing number of regulatory submissions are incorporating real world evidence to support observations on safety… https://t.co/TxVeaNMOnp)

RT @FDA_Drug_Info: #FDA launches Model-Informed Drug Development (MIDD) Pilot Program: https://t.co/DMAl4PSFv4.

RT @FDA_ORA: How many arrests did #OCI make last year? How many warning letters were issued? Learn all about #FDAORA 2017 achiev… https://t.co/Y753ErJtXj

RT @foodsafetygov: Do you have recalled eggs at home? Throw them out or return them. Wash and sanitize refrigerator drawers and shelve… https://t.co/qwO7vd61Ck

I want to thank @FrankPallone and @RutgersU for hosting me in my home state NJ today to tour innovation being led by Rutgers in continuous manufacturing. These manufacturing methods hold out much public health promise and #FDA appreciates @FrankPallone le

Today, patients with opioid use disorder will share experiences with #FDA in a public mtg; part of our work to encourage patient-focused development of new treatments for OUDs. We want to hear from patients about current treatments and what barriers stand

RT @FDAMedia: Statement from @SGottliebFDA on new efforts to enhance and modernize the FDA’s approach to medical device safety an… https://t.co/AjPV65a73n

RT @RAPSorg: Model-Informed Drug Development: Details on @US_FDA Pilot Project | #Regulatory Focus https://t.co/gzZWDKpfoL #FDA #pharma #PDUFA

Like our efforts around tobacco, #FDA’s comprehensive nutrition strategy is one of our greatest opportunities to have a profound and generational impact on human health https://t.co/AnOhC21qtI

RT @BioCentury: FDA launches model-informed drug development pilot https://t.co/CV1CxmDNdm

For #PFDD meeting on chronic pain, #FDA is interested in hearing from patients who experience chronic pain managed w/ analgesic medications (opioids, acetaminophen, NSAIDs, antidepressants, other medications) or non-pharmacologic interventions/therapies: